Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial

K. Kent Chevli; Neal D. Shore; Andrew Trainer; Angela B. Smith; Daniel Saltzstein; Yaron Ehrlich; Jay D. Raman; Boris Friedman; Richard D'Anna; David Morris; Brian Hu; Mark Tyson; Alexander Sankin; Max Kates; Jennifer Linehan; Douglas Scherr; Steven Kester; Michael Verni; Karim Chamie; Lawrence Karsh; Arnold Cinman; Andrew Meads; Soumi Lahiri; Madlen Malinowski; Nimrod Gabai; Sunil Raju; Mark Schoenberg; Elyse Seltzer; William C. Huang

doi:10.1097/JU.0000000000002186

Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial

K. Kent Chevli, Neal D. Shore, Andrew Trainer, Angela B. Smith, Daniel Saltzstein, Yaron Ehrlich, Jay D. Raman, Boris Friedman, Richard D'Anna, David Morris, Brian Hu, Mark Tyson, Alexander Sankin, Max Kates, Jennifer Linehan, Douglas Scherr, Steven Kester, Michael Verni, Karim Chamie, Lawrence KarshArnold Cinman, Andrew Meads, Soumi Lahiri, Madlen Malinowski, Nimrod Gabai, Sunil Raju, Mark Schoenberg, Elyse Seltzer, William C. Huang

Urology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	61-68
Number of pages	8
Journal	The Journal of urology
Volume	207
Issue number	1
DOIs	https://doi.org/10.1097/JU.0000000000002186
State	Published - Jan 1 2022

ASJC Scopus Subject Areas

Urology

Keywords

clinical trial
mitomycin
phase II
urinary bladder neoplasms

Access to Document

10.1097/JU.0000000000002186

OpenUrl availability

Full text

Cite this

Chevli, K. K., Shore, N. D., Trainer, A., Smith, A. B., Saltzstein, D., Ehrlich, Y., Raman, J. D., Friedman, B., D'Anna, R., Morris, D., Hu, B., Tyson, M., Sankin, A., Kates, M., Linehan, J., Scherr, D., Kester, S., Verni, M., Chamie, K., ... Huang, W. C. (2022). Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial. The Journal of urology, 207(1), 61-68. https://doi.org/10.1097/JU.0000000000002186

Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial. / Chevli, K. Kent; Shore, Neal D.; Trainer, Andrew et al.
In: The Journal of urology, Vol. 207, No. 1, 01.01.2022, p. 61-68.

Research output: Contribution to journal › Article › peer-review

Chevli, KK, Shore, ND, Trainer, A, Smith, AB, Saltzstein, D, Ehrlich, Y, Raman, JD, Friedman, B, D'Anna, R, Morris, D, Hu, B, Tyson, M, Sankin, A, Kates, M, Linehan, J, Scherr, D, Kester, S, Verni, M, Chamie, K, Karsh, L, Cinman, A, Meads, A, Lahiri, S, Malinowski, M, Gabai, N, Raju, S, Schoenberg, M, Seltzer, E & Huang, WC 2022, 'Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial', The Journal of urology, vol. 207, no. 1, pp. 61-68. https://doi.org/10.1097/JU.0000000000002186

@article{9038945b38054ba387d54856f07b0cce,

title = "Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial",

keywords = "clinical trial, mitomycin, phase II, urinary bladder neoplasms",

author = "Chevli, {K. Kent} and Shore, {Neal D.} and Andrew Trainer and Smith, {Angela B.} and Daniel Saltzstein and Yaron Ehrlich and Raman, {Jay D.} and Boris Friedman and Richard D'Anna and David Morris and Brian Hu and Mark Tyson and Alexander Sankin and Max Kates and Jennifer Linehan and Douglas Scherr and Steven Kester and Michael Verni and Karim Chamie and Lawrence Karsh and Arnold Cinman and Andrew Meads and Soumi Lahiri and Madlen Malinowski and Nimrod Gabai and Sunil Raju and Mark Schoenberg and Elyse Seltzer and Huang, {William C.}",

year = "2022",

month = jan,

day = "1",

doi = "10.1097/JU.0000000000002186",

language = "English",

volume = "207",

pages = "61--68",

journal = "The Journal of urology",

issn = "0022-5347",

number = "1",

}

TY - JOUR

T1 - Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II)

T2 - A Phase 2b, Open-Label, Single-Arm Trial

AU - Chevli, K. Kent

AU - Shore, Neal D.

AU - Trainer, Andrew

AU - Smith, Angela B.

AU - Saltzstein, Daniel

AU - Ehrlich, Yaron

AU - Raman, Jay D.

AU - Friedman, Boris

AU - D'Anna, Richard

AU - Morris, David

AU - Hu, Brian

AU - Tyson, Mark

AU - Sankin, Alexander

AU - Kates, Max

AU - Linehan, Jennifer

AU - Scherr, Douglas

AU - Kester, Steven

AU - Verni, Michael

AU - Chamie, Karim

AU - Karsh, Lawrence

AU - Cinman, Arnold

AU - Meads, Andrew

AU - Lahiri, Soumi

AU - Malinowski, Madlen

AU - Gabai, Nimrod

AU - Raju, Sunil

AU - Schoenberg, Mark

AU - Seltzer, Elyse

AU - Huang, William C.

PY - 2022/1/1

Y1 - 2022/1/1

KW - clinical trial

KW - mitomycin

KW - phase II

KW - urinary bladder neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85121912796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121912796&partnerID=8YFLogxK

U2 - 10.1097/JU.0000000000002186

DO - 10.1097/JU.0000000000002186

M3 - Article

C2 - 34433303

AN - SCOPUS:85121912796

SN - 0022-5347

VL - 207

SP - 61

EP - 68

JO - The Journal of urology

JF - The Journal of urology

IS - 1

ER -

Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this